Eli Lilly reports Q2 EPS of $3.92, exceeding expectations. Revenue reaches $11.30 billion, driven by strong drug sales….
Read More
Other Posts
- Related Articles
- More from Author
Eli Lilly reports Q2 EPS of $3.92, exceeding expectations. Revenue reaches $11.30 billion, driven by strong drug sales….
Read More
Subscribe to the FX Guys newsletter to get the latest FX Intel straight to your inbox.